Intuitive Surgical, Inc. $ISRG Stock Acquired by Woodstock Corp

Key Points

• Woodstock Corp increased its Intuitive Surgical stake by 4.3% in the third quarter, bringing its holdings to 84,643 shares valued at approximately $34.4 million. Institutional investors collectively own 83.64% of ISRG.
• Wall Street’s consensus rating remains “Moderate Buy,” with an average price target of $501.98, although several analysts recently lowered targets or downgraded the stock to neutral or hold.
• Intuitive Surgical beat quarterly expectations, reporting $2.80 in adjusted EPS and $2.89 billion in revenue, with revenue rising 18.4% year over year. Meanwhile, insiders sold 12,370 shares worth roughly $4.9 million over the past three months.

Woodstock Corp lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,643 shares of the medical equipment provider's stock after purchasing an additional 3,503 shares during the period. Intuitive Surgical comprises approximately 2.8% of Woodstock Corp's investment portfolio, making the stock its 8th largest holding. Woodstock Corp's holdings in Intuitive Surgical were worth $34,418,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in ISRG. Invesco Ltd. boosted its stake in Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider's stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the last quarter. Bank of America Corp DE grew its holdings in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock valued at $1,667,388,000 after purchasing an additional 116,292 shares during the period. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical in the second quarter worth $1,335,753,000. Amundi increased its position in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after buying an additional 193,096 shares during the last quarter. Finally, J. Stern & Co. LLP increased its position in Intuitive Surgical by 18,504.6% in the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider's stock worth $1,204,788,000 after buying an additional 2,115,814 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several research reports. UBS Group assumed coverage on Intuitive Surgical in a research note on Tuesday, July 28th. They set a "neutral" rating and a $500.00 price target for the company. Leerink Partners cut their target price on shares of Intuitive Surgical from $573.00 to $454.00 and set an "outperform" rating for the company in a research report on Friday, July 17th. Citigroup lowered their price target on shares of Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating on the stock in a research report on Friday, July 17th. HSBC downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective for the company. in a report on Thursday, July 30th. Finally, Mizuho set a $500.00 target price on Intuitive Surgical and gave the stock a "neutral" rating in a research report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $501.98.

Insider Buying and Selling at Intuitive Surgical

In related news, VP Fredrik Widman sold 1,089 shares of the firm's stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $374.44, for a total value of $407,765.16. Following the sale, the vice president directly owned 1,026 shares of the company's stock, valued at $384,175.44. This trade represents a 51.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. This represents a 0.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $427.64 on Tuesday. The company has a market capitalization of $151.08 billion, a PE ratio of 48.99, a price-to-earnings-growth ratio of 3.20 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The business's fifty day moving average is $387.41 and its 200 day moving average is $410.47.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter last year, the company posted $1.81 EPS. The company's revenue for the quarter was up 18.4% on a year-over-year basis. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.